reported fourth-quarter earnings of $4.1 million, or 1 cent a share, a swing from year-earlier loss.
Earnings on an adjusted basis were 33 cents a share, topping the estimates of analysts.
Revenue in the quarter was $1.35 billion vs. $1.2 billion a year earlier.
Analysts surveyed by Thomson Reuters expected Mylan, a drugmaker, to earn 30 cents a share on revenue of $1.25 billion.
Mylan reaffirmed its 2010 guidance of $1.50 to $1.70 a share, and said it expects earnings of more than $2 a share in 2011 and greater than $2.73 a share in 2013.
-- Reported by Joseph Woelfel in New York.
Follow TheStreet.com on
and become a fan on